Documents
Application Sponsors
NDA 211488 | FORSEE PHARMACEUTICALS CO., LTD. | |
Marketing Status
Application Products
001 | EMULSION;SUBCUTANEOUS | EQ 42 MG BASE | 2 | CAMCEVI KIT | LEUPROLIDE MESYLATE |
FDA Submissions
TYPE 2; Type 2 - New Active Ingredient | ORIG | 1 | AP | 2021-05-25 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
FORSEE PHARMACEUTICALS CO., LTD.
cder:Array
(
[0] => Array
(
[ApplNo] => 211488
[companyName] => FORSEE PHARMACEUTICALS CO., LTD.
[docInserts] => ["",""]
[products] => [{"drugName":"CAMCEVI KIT","activeIngredients":"LEUPROLIDE MESYLATE","strength":"EQ 42 MG BASE","dosageForm":"EMULSION;SUBCUTANEOUS","marketingStatus":"Prescription","te":"","rld":"TBD","rs":"No"}]
[labels] => [{"actionDate":"05\/25\/2021","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/211488s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"05\/25\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 2 - New Active Ingredient","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2021\\\/211488s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/211488Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2021-05-25
)
)